Market Closed -
Other stock markets
|
Pre-market 07:41:13 am | |||
1.165 USD | +3.10% | 1.19 | +2.15% |
01:07pm | X4 Pharmaceuticals Gets FDA Approval for Xolremdi Capsules | DJ |
Mar. 21 | Transcript : X4 Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.94% | 196M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.61% | 22.15B | |
-17.37% | 21.02B | |
-8.61% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- XFOR Stock
- News X4 Pharmaceuticals, Inc.
- Transcript : X4 Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 21, 2024